Metro has its sights on gradually returning to profit growth in the new fiscal year as the Canadian food retailer focuses on efficiency gains and improving service after wrapping up a multi-year ...

Inc.’s stock TJX rose slightly early Wednesday, after the discount retailer’s fiscal third-quarter earnings topped estimates and it raised guidance. The company had net income of $1.297 billion, or $1 ...

Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering. The stock was down 7.3% at $35.75 in premarket trading on ...

Target’s stock set to suffer worst day in more than two years after profit, revenue, comparable sales and the outlook were ...

The S&P 500 has bounced from its drop last week, a decline that had eroded its U.S. election bump without knocking the index ...

The chances of another rate cut this year by the Bank of England has diminished after data showed an acceleration in the pace of Britain’s inflation last month.

Analysts tracked by FactSet expect Nvidia to post 75 cents in adjusted earnings per share for the fiscal third quarter, up from 40 cents a year before. The FactSet consensus calls for $33.2 billion in ...

Applications for mortgages in the latest week rose in spite of the 30-year rate inching up for the fourth week in a row to ...

Delta Air Lines Inc. DAL on Wednesday reiterated its fourth-quarter financial outlook as the carrier laid out long-term goals as part of its investor day. Delta said two-thirds of millennials are ...

Sage Therapeutics shares tumbled in premarket trading Wednesday after the biopharmaceutical company threw in the towel on dalzanemdor following the drug candidate's latest study failure. Sage shares, ...

Pfizer said the green light makes Hympavzi the first once-weekly subcutaneous treatment in the European Union for people with severe hemophilia B and the first to be administered via a pre-filled pen ...

Pfizer Inc. PFE named oncology chief Chris Boshoff as its new chief scientific officer on Wednesday, replacing Mikael Dolsten starting Jan. 1. The drug company had been searching for a new chief ...